---
title: "MDR rule 2: Channelling or storing blood, liquids, tissues or gases"
url: https://normiq.app/en/classification/mdr/rule-2
language: en
updated: 2026-11-15
---

# MDR rule 2: Channelling or storing blood, liquids, tissues or gases

MDR · Annex VIII, Section 4.2 · NON-INVASIVE DEVICES

Updated on November 15, 2026

## Official text

All non-invasive devices intended for channelling or storing blood, body liquids, cells or tissues, liquids or gases for the purpose of eventual infusion, administration or introduction into the body are classified as class IIa:

- if they may be connected to a class IIa, class IIb or class III active device; or
- if they are intended for use for channelling or storing blood or other body liquids or for storing organs, parts of organs or body cells and tissues, except for blood bags; blood bags are classified as class IIb.

In all other cases, such devices are classified as class I.

MDR, Annex VIII, Section 4.2, consolidated version of July 19, 2026.

Short link: [normiq.app/en/mdr/annexe/viii/2](https://normiq.app/en/mdr/annexe/viii/2)

## In plain words

The rule covers non-invasive devices that channel or store blood, body liquids, cells or tissues, liquids or gases for eventual infusion, administration or introduction into the body. They are in class IIa if they may be connected to an active device of class IIa, IIb or III, or if they channel or store blood or other body liquids, or store organs, cells or tissues; blood bags are in class IIb, and all others in class I.

Explanation written by Normiq; only the official text above is authoritative.

## Examples from the MDCG guidance

The guidance lists these examples under rule 2 (MDCG 2021-24 Rev.1). It is not legally binding, and the class always depends on the intended purpose of the device (Annex VIII, Section 3.1).

### Class I

- Non-invasive devices that provide a simple channelling function, with gravity providing the force to transport the liquid, e.g. administration sets for infusion

  MDCG 2021-24 Rev.1, 4.2, Rule 2, p. 30

### Class IIa

- Syringes for infusion pumps

  MDCG 2021-24 Rev.1, 4.2, Rule 2, p. 29

### Class IIb

- Blood bags without a substance which, if used separately, can be considered to be a medicinal product

  MDCG 2021-24 Rev.1, 4.2, Rule 2, p. 30

## Classes and Normiq roadmaps

Rule 2 assigns: Class I, Class IIa, Class IIb. For each, the Normiq roadmap on every market where Annex VIII applies.

### Class I

- [European Union 14 phases · 63 steps · estimated duration 210 days See the roadmap →](https://normiq.app/en/roadmap/eu/class-i)
- [Switzerland 14 phases · 69 steps · estimated duration 60 days See the roadmap →](https://normiq.app/en/roadmap/switzerland/class-i)
- [European Union and Switzerland 15 phases · 77 steps · estimated duration 240 days See the roadmap →](https://normiq.app/en/roadmap/eu-switzerland/class-i)

### Class IIa

- [European Union 15 phases · 66 steps · estimated duration 240 days See the roadmap →](https://normiq.app/en/roadmap/eu/class-iia)
- [Switzerland 16 phases · 74 steps · estimated duration 120 days See the roadmap →](https://normiq.app/en/roadmap/switzerland/class-iia)
- [European Union and Switzerland 17 phases · 82 steps · estimated duration 300 days See the roadmap →](https://normiq.app/en/roadmap/eu-switzerland/class-iia)

### Class IIb

- [European Union 15 phases · 68 steps · estimated duration 360 days See the roadmap →](https://normiq.app/en/roadmap/eu/class-iib)
- [Switzerland 16 phases · 77 steps · estimated duration 180 days See the roadmap →](https://normiq.app/en/roadmap/switzerland/class-iib)
- [European Union and Switzerland 17 phases · 85 steps · estimated duration 420 days See the roadmap →](https://normiq.app/en/roadmap/eu-switzerland/class-iib)

## The same rule in Switzerland

> Devices shall be divided into classes I, IIa, IIb and III, taking into account the intended purpose of the devices and their inherent risks. This classification must comply with the provisions of Annex VIII to EU-MDR, taking account of the implementing acts of the European Commission listed in Annex 5a.

Fedlex’s English translation, which has no legal force: the ordinance is official only in French, German and Italian.

[Art. 15 MedDO](https://www.fedlex.admin.ch/eli/cc/2020/552/en#art_15)

The families of rules, the cross-cutting criteria, Rule 11 and common pitfalls are explained in the guide: [MDR classification: the 22 rules of Annex VIII explained](https://normiq.app/en/guides/classification-mdr-annexe-viii)

## Classify your device

The tool asks the questions of the 22 rules of the MDR, one at a time, and gives the indicative class with the rule and its text.

[Open the classification tool](https://normiq.app/en/classification#outil)

## Official sources

- [MDR, consolidated version of July 19, 2026 (02017R0745-20260719), EUR-Lex](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02017R0745-20260719)
- [MDCG 2021-24 Rev.1, “Guidance on classification of medical devices”, April 2026, p. 29, 30](https://health.ec.europa.eu/document/download/cbb19821-a517-4e13-bf87-fdc6ddd1782e_en?filename=mdcg_2021-24_en.pdf)
